Skip to content
flubromazolam

Structure via PubChem · Public domain (PubChem)

EntityQ5462609· pop 12· linked from 637 articles

flubromazolam

Sign in to save

Flubromazolam (JYI-73) is a triazolobenzodiazepine (TBZD), which are benzodiazepine (BZD) derivatives. Flubromazolam is reputed to be highly potent, and concerns have been raised that clonazolam and flubromazolam in particular may pose comparatively higher risks than other designer benzodiazepines, due to their ability to produce strong sedation and amnesia at oral doses of as little as 0.5 mg. Life-threatening adverse reactions have been observed at doses of only 3 mg of flubromazolam.

Key facts

Drug.Verifiedfields
changed
Drug.Watchedfields
changed
Drug.IUPAC_name
8-bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a] [1,4]benzodiazepine
Drug.image
Flubromazolam.svg
Drug.image_class
skin-invert-image
Drug.width
200
Drug.legal_BR
B1
Drug.legal_CA
Schedule IV
Drug.legal_DE
Anlage II
Drug.legal_UK
PSA
Drug.legal_US
Schedule I
Drug.legal_status
Illegal in Sweden and Switzerland
Drug.CAS_number
612526-40-6
Drug.PubChem
21930924
Drug.ChemSpiderID
10684757
Drug.UNII
1BF1HN5GWD
Drug.KEGG
C22817
Drug.C
17

via Wikipedia infobox

Chemical data

Formula
C17H12BrFN4
Molecular weight
371.2 g/mol
IUPAC name
8-bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
SMILES
CC1=NN=C2N1C3=C(C=C(C=C3)Br)C(=NC2)C4=CC=CC=C4F
InChIKey
VXGSZBZQCBNUIP-UHFFFAOYSA-N
XLogP
2
Polar surface area
43.1 Ų
H-bond donors
0
H-bond acceptors
4
Formal charge
0

via PubChem

Wikidata facts

Mass
370.023
Show 3 more facts
chemical formula
C₁₇H₁₂BrFN₄
canonical SMILES
CC1=NN=C2N1C3=C(C=C(C=C3)Br)C(=NC2)C4=CC=CC=C4F
Commons category
Flubromazolam
Sources (2)

via Wikidata · CC0

~2 min read

Encyclopedic overview

8 sections
Contents
  • Legal status
  • Sweden
  • Switzerland
  • United Kingdom
  • Australia
  • United States
  • See also
  • References

Flubromazolam (JYI-73) is a triazolobenzodiazepine (TBZD), which are benzodiazepine (BZD) derivatives. Flubromazolam is reputed to be highly potent, and concerns have been raised that clonazolam and flubromazolam in particular may pose comparatively higher risks than other designer benzodiazepines, due to their ability to produce strong sedation and amnesia at oral doses of as little as 0.5 mg. Life-threatening adverse reactions have been observed at doses of only 3 mg of flubromazolam.

==Legal status==

Excerpted from Wikipedia’s “flubromazolam” article, available under the CC BY-SA 4.0 licence.